Literature DB >> 22584955

Codon 200 mutation of the prion gene: genotype-phenotype correlations.

Peter K Panegyres1, Judy G S Goh, Jack Goldblatt.   

Abstract

Genetic mutations as a cause of prion diseases are rare. We describe a large family with multiple affected members with the codon E200K prion mutation. To improve understanding of the genotype-phenotype correlations of prion gene mutations, clinical, genetic and neuropathological data were obtained from family members over 15 years. Six patients with the codon E200K mutation and 2 patients without the codon 200 mutation from this family were followed. The 6 patients with the codon 200 mutation had a mean age onset of 58.83 years (SD 7.2; lower 95 % CI 51.0; upper 95 % CI 66.4). The most common symptoms at onset were memory loss, walking difficulties and hallucinations. The most frequent neurological phenomena were a rapidly progressive dementia, eye movement abnormalities and ataxia. The mean duration of onset of symptoms to death was 3.9 months (SD 1.1; lower 95 % CI 2.8; upper 95 % CI 5.1). Two male patients developed neurodegenerative disorders unrelated to the prion codon 200 mutation: progressive supranuclear palsy and olivopontocerebellar degeneration. Their mean survival was 96 months (SD 33.9; p < 0.0001). Individuals from families with the prion codon 200 mutation may have a rapidly progressive dementia. Members of families with inherited prion mutations may be at risk of other neurodegenerative disorders unrelated to the prion mutation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22584955     DOI: 10.1007/s00415-012-6539-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  21 in total

1.  Codon 129 polymorphism and the E200K mutation do not affect the cellular prion protein isoform composition in the cerebrospinal fluid from patients with Creutzfeldt-Jakob disease.

Authors:  Matthias Schmitz; Markus Schlomm; Badrul Hasan; Michael Beekes; Eva Mitrova; Carsten Korth; Andreas Breil; Julie Carimalo; Joanna Gawinecka; Daniela Varges; Inga Zerr
Journal:  Eur J Neurosci       Date:  2010-05-31       Impact factor: 3.386

2.  New haplotype of familial Creutzfeldt-Jakob disease with a codon 200 mutation and a codon 219 polymorphism of the prion protein gene in a Japanese family.

Authors:  H Seno; H Tashiro; H Ishino; T Inagaki; M Nagasaki; S Morikawa
Journal:  Acta Neuropathol       Date:  2000-02       Impact factor: 17.088

3.  Creutzfeldt-Jakob disease risk in Slovak recipients of human pituitary growth hormone.

Authors:  E Mitrova; G Belay
Journal:  Bratisl Lek Listy       Date:  1999-04       Impact factor: 1.278

4.  Diffusion-weighted MRI in familial Creutzfeldt-Jakob disease with the codon 200 mutation in the prion protein gene.

Authors:  Yoshio Tsuboi; Yasuhiko Baba; Katsumi Doh-ura; Akiko Imamura; Shinsuke Fujioka; Tatsuo Yamada
Journal:  J Neurol Sci       Date:  2005-05-15       Impact factor: 3.181

5.  Prion protein glycotype analysis in familial and sporadic Creutzfeldt-Jakob disease patients.

Authors:  F Cardone; Q G Liu; R Petraroli; A Ladogana; M D'Alessandro; C Arpino; M Di Bari; G Macchi; M Pocchiari
Journal:  Brain Res Bull       Date:  1999-08       Impact factor: 4.077

Review 6.  The genetics of prion diseases.

Authors:  James A Mastrianni
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

7.  Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation.

Authors:  J Chapman; P Brown; L G Goldfarb; A Arlazoroff; D C Gajdusek; A D Korczyn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-10       Impact factor: 10.154

8.  Rhythmic pupillary oscillation in Creutzfeldt-Jakob disease associated with the Glu/Lys mutation of prion protein codon 200.

Authors:  Kaori Nagasaka; Emiko Ohta; Takamura Nagasaka; Shinji Togashi; Michiaki Miwa; Yuki Nakamura; Kazumasa Shindo; Zenji Shiozawa
Journal:  Mov Disord       Date:  2010-01-15       Impact factor: 10.338

9.  Demyelinating peripheral neuropathy with Creutzfeldt-Jakob disease and mutation at codon 200 of the prion protein gene.

Authors:  J C Antoine; J L Laplanche; J F Mosnier; P Beaudry; J Chatelain; D Michel
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

10.  Focal dystonia as the presenting sign in Creutzfeldt-Jakob disease.

Authors:  Mark A Hellmann; Eldad Melamed
Journal:  Mov Disord       Date:  2002-09       Impact factor: 10.338

View more
  4 in total

Review 1.  Lacritin and other autophagy associated proteins in ocular surface health.

Authors:  Roy Karnati; Venu Talla; Katherine Peterson; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2015-08-25       Impact factor: 3.467

2.  Biological network inferences for a protection mechanism against familial Creutzfeldt-Jakob disease with E200K pathogenic mutation.

Authors:  Sol Moe Lee; Myungguen Chung; Kyu Jam Hwang; Young Ran Ju; Jae Wook Hyeon; Jun-Sun Park; Chi-Kyeong Kim; Sangho Choi; Jeongmin Lee; Su Yeon Kim
Journal:  BMC Med Genomics       Date:  2014-08-22       Impact factor: 3.063

3.  Movement Disorders in Prionopathies: A Systematic Review.

Authors:  Federico Rodriguez-Porcel; Vinícius Boaratti Ciarlariello; Alok K Dwivedi; Lilia Lovera; Gustavo Da Prat; Ricardo Lopez-Castellanos; Ritika Suri; Holly Laub; Ruth H Walker; Orlando Barsottini; José Luiz Pedroso; Alberto J Espay
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-12-12

Review 4.  Prion diseases: immunotargets and therapy.

Authors:  Jennifer T Burchell; Peter K Panegyres
Journal:  Immunotargets Ther       Date:  2016-06-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.